Galapagos NV
GLPG
#4738
Rank
A$2.86 B
Marketcap
A$42.69
Share price
-1.14%
Change (1 day)
11.97%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): A-$0.71

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is A-$0.49. In 2024 the company made an earnings per share (EPS) of A$1.69 a decrease over its 2023 EPS that were of A$5.15.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.71-141.72%
2024A$1.69-67.16%
2023A$5.15-199.64%
2022A-$5.1799.03%
2021A-$2.60-68.98%
2020A-$8.37-298.06%
2019A$4.23-554.64%
2018A-$0.93-77.18%
2017A-$4.07-326.21%
2016A$1.80-134.19%
2015A-$5.27-371.34%
2014A$1.94-445.98%
2013A-$0.5632.88%
2012A-$0.42-82.07%
2011A-$2.36-817.9%
2010A$0.3312.73%
2009A$0.29-120.79%
2008A-$1.40-37.67%
2007A-$2.2539.64%
2006A-$1.6128.17%
2005A-$1.256.25%
2004A-$1.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$16.16-3,384.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$5.44-1,205.90%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$3.47-805.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$3.00-708.98%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$10.61-2,255.70%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$8.61-1,848.66%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$5.47-1,211.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
A-$0.89 79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$1.80-465.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel